A Study of SC-011 Alone and in Combination With ABBV-181 in Subjects With Relapsed or Refractory Small Cell Lung Cancer

Condition:   Small Cell Lung Cancer Interventions:   Drug: SC-011;   Drug: ABBV-181 Sponsor:   AbbVie Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials